Mss51tm1(KOMP)Vlcg
Targeted Allele Detail
|
Symbol: |
Mss51tm1(KOMP)Vlcg |
Name: |
MSS51 mitochondrial translational activator; targeted mutation 1, Velocigene |
MGI ID: |
MGI:5312367 |
Synonyms: |
Zmynd17LacZ |
Gene: |
Mss51 Location: Chr14:20532935-20546969 bp, - strand Genetic Position: Chr14, 11.53 cM, cytoband B
|
Alliance: |
Mss51tm1(KOMP)Vlcg page
|
IMPC: |
Mss51 gene page |
|
Mutant Cell Lines: |
14311E-C1, 14311E-G5, 14311E-G12 |
Germline Transmission: |
Earliest citation of germline transmission:
J:280597
|
Parent Cell Line: |
VGB6 (ES Cell)
|
Strain of Origin: |
C57BL/6NTac
|
Project Collection: |
KOMP-Regeneron
|
|
Allele Type: |
|
Targeted (Null/knockout, Reporter) |
Mutations: |
|
Insertion, Intragenic deletion
Vector: ZEN-Ub1
|
|
|
Mutation details: The insertion of Velocigene cassette ZEN-Ub1 created a deletion of size 4599bp between positions 20533128-20537726 of Chromosome 14 (Build GRCm39).
(J:136110)
|
|
|
Key: |
hm |
homozygous |
ht |
heterozygous |
tg |
involves transgenes |
√ |
phenotype observed |
cn |
conditional genotype |
cx |
complex: > 1 genome feature |
ot |
other: hemizygous, indeterminate,... |
N |
normal phenotype |
|
Genotype/ Background: |
| Allelic Composition | Genetic Background | Cell Line(s) |
---|
Loading... | | | involves: C57BL/6NTac | 14311E-G5 |
|
Phenotypes: |
Affected Systems |
|
|
adipose tissue
|
√
|
decreased inguinal fat pad weight
|
√
|
behavior/neurological
|
√
|
decreased aerobic running capacity
|
√
|
cellular
|
√
|
abnormal mitochondrial morphology
|
√
|
increased mitochondrial DNA content
|
√
|
abnormal mitochondrial crista morphology
|
√
|
abnormal mitochondrial shape
|
√
|
abnormal mitochondrial physiology
|
√
|
growth/size/body
|
√
|
increased liver weight
|
√
|
homeostasis/metabolism
|
√
|
decreased aerobic running capacity
|
√
|
increased fasting circulating glucose level
|
√
|
increased circulating insulin level
|
√
|
impaired glucose tolerance
|
√
|
increased skeletal muscle glycogen level
|
√
|
insulin resistance
|
√
|
liver/biliary system
|
√
|
increased liver weight
|
√
|
hepatic steatosis
|
√
|
muscle
|
√
|
abnormal muscle morphology
|
√
|
increased skeletal muscle glycogen level
|
√
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
Mutant cell line 14311E-G5 was used to create mutant mice which demonstrated germline transmission. J:280597.
|
Original: |
J:136110 Velocigene, Alleles produced for the KOMP project by Velocigene (Regeneron Pharmaceuticals). MGI Direct Data Submission. 2008; |
All: |
3 reference(s) |
|